ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Studies on novel compound BCR-ABL mutations associated with multiple TKI resistance will help understand mechanism of drug resistance in CML in more depth and will lead to better drug resistance management strategies to improve CML survival, possibly leading to a potential cure